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Abstract
Introduction: One third of the world’s population is estimated to be latently infected with Mycobacterium tuberculosis (LTBI).
Surveys of LTBI are rarely performed in resource poor TB high endemic countries like Tanzania although low-income
countries harbor the largest burden of the worlds LTBI. The primary objective was to estimate the prevalence of LTBI in
household contacts of pulmonary TB cases and a group of apparently healthy neighborhood controls in an urban setting of
such a country. Secondly we assessed potential impact of LTBI on inflammation by quantitating circulating levels of an
acute phase reactant: alpha-1-acid glycoprotein (AGP) in neighborhood controls.
Methods: The study was nested within the framework of two nutrition studies among TB patients in Mwanza, Tanzania.
Household contacts- and neighborhood controls were invited to participate. The study involved a questionnaire, BMI
determination and blood samples to measure AGP, HIV testing and a Quantiferon Gold In tube (QFN-IT) test to detect signs
of LTBI.
Results: 245 household contacts and 192 neighborhood controls had available QFN-IT data. Among household contacts,
the proportion of QFT-IT positive was 59% compared to 41% in the neighborhood controls (p = 0.001). In a linear regression
model adjusted for sex, age, CD4 and HIV, a QFT-IT positive test was associated with a 10% higher level of alpha-1-acid
glycoprotein(AGP) (10B 1.10, 95% CI 1.01; 1.20, p = 0.03), compared to individuals with a QFT-IT negative test.
Conclusion: LTBI is highly prevalent among apparently healthy urban Tanzanians even without known exposure to TB in the
household. LTBI was found to be associated with elevated levels of AGP. The implications of this observation merit further
studies.
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Introduction
One third of the world’s population is estimated to be latently
infected with Mycobacterium tuberculosis (LTBI) [1]. From this
immense pool, around 200 million people will eventually progress
to active tuberculosis (TB), and in this way fuel the TB epidemic
[2]. Several factors are associated with the progression from LTBI
to active TB such as malnutrition, smoking, diabetes, and
compromised immunity with HIV being one of the strongest risk
factors [3].
The Tuberculin Skin Test (TST), developed by R. Koch in
1890 and refined by C. Mantoux in 1907, is widely used to detect
LTBI. However, the TST has some important limitations such as
low specificity among Bacilli Calmette-Gue´rin (BCG) vaccinated
individuals [4] and a relatively low sensitivity in immune
compromised individuals [5].
During the recent decade new immunological tests for
diagnosing M. tuberculosis infection have been developed. The
Interferon-c (IFN-c) release assays (IGRA) are in vitro assays
measuring the IFN-c release of sensitized T-cells after exposure to
M. tuberculosis antigens. The M. tuberculosis antigens used are
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encoded in the Region of Difference-1, a part of the genome which
is absent in all BCG vaccine strains as well as in most non-
tuberculous mycobacteria [6]. Latent TB infection is often
perceived as a completely inert ‘‘bystander’’ infection, with no
influence on the host. However, we know that a proportion of
LTBI at some point reactivate and develop active disease, and this
may be preceded by a ‘‘fight’’ between host and microorganism
leading to inflammatory responses that could have long term
impact on the infected person. The acute phase reactant alpha-1-
acid glycoprotein (AGP) has previously been associated with active
TB [7,8] and it might be a marker of inflammation in regards to
LTBI. The primary objective was to estimate the prevalence of
LTBI in household contacts of pulmonary TB cases and a group of
apparently healthy neighborhood controls in an urban setting in a
TB high endemic country. The secondary objective was to detect
signs of inflammation in persons with LTBI by measuring AGP.
Methods
Ethics Statement
Ethical permission was obtained from the Medical Research
Coordinating committee of the National Institute for Medical
Research (NIMR) in Tanzania. Study approval was given by The
Danish Central Medical Ethics Committee. Written and oral
information was presented to all eligible participants by the health
staff before written informed consent was obtained. Written
consent was obtained from parents/legal guardians of any
participants between 15–18 years of age. Pre-HIV test counseling
was compulsory, and post-HIV-test counseling was offered to all
HIV-positive participants. Patients diagnosed with HIV were
referred for further management.
Study Environment
The present study was nested within the framework of two
nutrition studies among newly diagnosed TB patients [9,10], from
where a number of non-TB individuals were invited to participate
as controls. The present study was conducted from January 2007
to May 2008 at four TB clinics in Tanzania’s second largest city
Mwanza, and it is based on data from the non-TB participants. All
non-TB participants recruited within this period (n= 455) were
invited to participate in the present study. The TB clinics cover
most of the city area including periurban districts, thus the
participants were recruited from a wide city area with varying
socio-demography. Mwanza city holds approximately half a
million inhabitants, and is located on the southern shores of Lake
Victoria. Mwanza city is administratively divided into 21 wards,
208 sub-wards and about 500 streets. Each street is further divided
into an informal communal cell with 10–20 households (ten-cell),
headed by a ten-cell leader.
Recruitment and Eligibility
To serve as non-TB controls for the TB study, individuals from
the neighborhood of TB patients as well as individuals from the
household of TB patients were invited to participate in the present
study. To be eligible, only adult (.15 years) participants were
invited. Furthermore, the participants were not eligible if they had
any history of TB, evidence of active TB (cough, intermittent
fevers, excessive night sweating in the past two weeks, unexplained
weight loss in the past month), were pregnant or lactating,
suffering from other severe diseases, or non-residents of Mwanza
City. The participants HIV status did not influence the eligibility.
The neighborhood controls. The TB cases participating in
the nutrition studies [9,10] were asked to provide detailed contact
information about their ten-cell leader, and in co-operation with
the ten-cell leader a complete list of individuals from the same ten-
cell, with the same sex and similar age (+/25 years) as the case,
was made. From the list one individual was randomly selected by
drawing a number from a hat. The number corresponds to a name
in the list given by the ten cell leader. The individual was invited to
participate as neighborhood control. None of the neighborhood
controls were household contacts of a TB patient. If the invited
control was not eligible another was randomly selected from the
list. The recruitment was performed in weekdays during daytime
between 8 am and 5 pm.
The household contacts. The TB patients from which the
neighborhood controls were invited also provided acceptance for a
staff member to visit the household of the TB patient. Within the
household one eligible individual was randomly selected using
same method as above mentioned. The recruitment was
performed in weekdays during daytime between 8 am and 5 pm.
Study Assessment and Measurement
At recruitment all individuals were interviewed by a health care
worker using a questionnaire about socio-demographical informa-
tion.
Weight and height of the participants were measured (nearest
0.1 kg and 0.1 cm), from which Body mass index (bmi) (kg/m2)
was derived. For each participant the presence or absence of a
BCG scar was determined by a trained nurse at the TB clinic.
Laboratory Analyses
Blood samples were collected in heparinized tubes (Lithium
heparinized plasma containers 4 ml, Becton Dickinson (BD)
VacutainerH, BD Brøndby, DK) and transported to the central
study laboratory within 8 hours. HIV testing was performed in
duplicates, using rapid tests Determine HIV 1/2 (Inverness
Medical Innovations, Inc.) and Capillus HIV-1/HIV-2 (Trinity
Biotech Plc.). If discordance was found between the two tests a
confirmatory ELISA test was performed (OrganonUniform II,
Organon Teknia, NL).
Cluster of differentiation 4 (CD4) count was obtained by flow
cytometry after CD4 immuno-flourochrome staining of the
leucocytes using the Partec Facs machine (GmbH. Mu¨nster,
FRG). Also hemoglobin levels (g/dL), white blood cell (WBC)
(109/L) counts (including differentials), were analyzed at the
central laboratory.
For neighborhood controls only, serum concentrations of the
acute phase reactant alpha-1-acid glycoprotein (AGP) were
determined at the Department of Clinical Biochemistry, Aalborg
University Hospital, DK.
TB Diagnostics Based on an IGRA
QuantiFERONH-TB gold In-tube method (QFT-
IT). Blood was collected from study participants in heparinized
tubes (Lithium heparinized plasma containers 4 ml, BD Vacutai-
nerH, BD, Brøndby, DK) in each of the four main study centers
and transported to the study laboratory within 8 hours. One ml of
blood was transferred to each of the three QFT-IT test blood
collection tubes pre-coated with (i) the TB-specific antigens, (ii) a
phytohemagglutinin (PHA) positive control (Mitogen) and (iii) a
negative (Nil) control tube, respectively. The samples were shaken
to ensure proper mixing of blood with contents and incubated
upright at temperature 37uC for 20–24 hours. They were
centrifuged at 3,0006g for 10 minutes and plasma was harvested
and collected in NuncH cryotubes (Nunc, Roskilde, DK) and
stored frozen at –80uC. Plasma samples were transported on dry
ice from Tanzania to Denmark, where ELISA testing was
performed as described by the manufacturer (www.cellestis.com).
Prevalence of Latent M. tuberculosis Infection
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ELISA readings were transferred to the QFT-Gold v.2.50
Software giving final QFT-IT test results. The QFT-IT result was
graded as positive if the IFN-c in plasma of the antigen-stimulated
blood was .0.35 IU/ml after subtracting the cytokine concen-
tration of unstimulated plasma and the stimulation index (IFN–c
concentration in plasma of antigen stimulated blood divided by
IFN–c concentration of unstimulated blood) was $1.25 regardless
of the mitogen stimulated IFN–c response. Responses were graded
as negative if the antigen-specific response was ,0.35 IU/ml and
the mitogen stimulated IFN-c response was $0.5 IU/ml.
Responses were indeterminate if either the IFN-c response in
the unstimulated sample was $8 IU/ml regardless of the antigen-
specific and the mitogen-stimulated responses or if both the
antigen-specific response was ,0.35 IU/ml and the mitogen-
stimulated IFN-c response was #0,5 IU/ml.
Statistical Analyses
Data were double entered, and all statistical analyses were
performed using Stata 11.0 (Stata Corp., Texas, USA). The
distribution of continuous variables was assessed for normality.
Chi squared and Fisher’s exact tests were used to test for
differences in proportions. The association between LTBI and the
level of acute phase response was assessed in a linear regression
model; the IGRA result (positive vs. negative) was included as
independent variable with log-transformed AGP as the outcome
variable. The model was further adjusted for age, sex, HIV status
and CD4 count. P-values ,0.05 were considered significant.
Results
Among 255 approached household contacts and 199 neighbor-
hood controls, a total of 245 (96%) household contacts and 192
(97%) neighborhood controls had available QFT-IT data and
were included in the present analyses. The mean (SD) age was
34.5 (12.8) years, median (IQR) bmi was 21.7 (19.9–24.2) kg/m2
and 54% (234) were females.
The overall HIV prevalence was 11% (48) and 92% (402) had
visible BCG scar. A summary of the baseline characteristics
stratified by household contacts and neighborhood controls are
shown in Table 1. Among household contacts, the proportion of
QFT-IT positive was 59% (145/245), (95% CI: 53–65%)
compared to 41% (78/192), (95% CI: 34–48%) in the neighbor-
hood controls (p = 0.001) (Table 2). The proportion of indeter-
minate results among household contacts and neighborhood
controls was 7% (16/245), (95% CI: 3.4–9.6%) and 8% (15/
192), (95% CI: 4.0–12%) (p= 0.74), respectively. Complete QFT-
IT results stratified by household contacts and neighborhood
controls are shown in Table 2. The QFT-IT results stratified by
HIV status are shown in Table 3. There was no association
between the QFT-IT result and the covariates: sex, age, BCG scar,
Table 1. Baseline characteristics of neighborhood controls (n = 192) and household contacts (n = 245) of tuberculosis patients.
Neighborhood controls Household contacts
N Mean [SD] or % (n) N Mean [SD] or % (n)
Female sex 192 43% (82) 245 62% (152)
Age, years 192 34 [11.99] 245 35 [13.43]
HIV positive 192 9% (17) 245 13% (31)
BCG scar 191 94% (180) 239 93% (222)
CD4 count, cell count/mL, HIV positive individuals 17 574.82 [848.20] 31 376.48 [262.20]
CD4 count, cell count/mL, HIV negative individuals 175 595.58 [318.52] 213# 655.68 [446.80]
Hemoglobin, g/dL 192 14.08 [2.41] 245 13.66 [2.43]
BMI, Kg/M2 192 22.33 [3.74] 244 22.67 [4.11]
Leukocytes, cells/mL 192 4798.96 [1340.70] 245 4977.76 [1642.10]
Neutrofile granulocytes, cells/mL 192 2117.26 [969.22] 245 2307.91 [1097.70]
AGP*, g/L 192 0.68 (0.59–0.85) 0 –
Data are mean [SD] or % (n) unless otherwise stated.
*Median (interquartile range).
#One missing CD4 count.
doi:10.1371/journal.pone.0064008.t001
Table 2. The QFT-IT results stratified by neighborhood
controls (n = 192) and household contacts (n = 245).
Neighborhood
controls Household contacts
N % (n) [95% CI] N % (n) [95% CI]
QFT-IT positive 192 41% (78) [34–48%] 245 59% (145) [53–65%]
QFT-IT negative 192 52% (99) [44–59%] 245 34% (84) [28–40%]
QFT-IT indeterminate 192 8% (15) [4.0–12%] 245 7% (16) [3.4–9.6%]
Data are proportions in % (n) with [95% CI].
doi:10.1371/journal.pone.0064008.t002
Table 3. The QFT-IT results stratified by HIV status (n = 437).
HIV positive HIV Negative
N % (n) [95% CI] N % (n) [95% CI]
QFT-IT positive 48 54% (26) [40–69%] 389 51% (197) [46–
56%]
QFT-IT negative 48 35% (17) [22–49%] 389 43% (166) [38–
48%]
QFT-IT indeterminate 48 10% (5) [1.7–19%] 389 7% (26) [4.2–9.1%]
Data are proportions in % (n) with [95% CI].
doi:10.1371/journal.pone.0064008.t003
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HIV status, CD4 count, hemoglobin, BMI, and WBCs (data not
shown).
However, in a multiple linear regression model with AGP (log-
transformed) as dependent variable and the QFT-IT result being
the predictor, the level of AGP was 10% higher (10B 1.10, 95% CI
1.01; 1.20, p = 0.03) among participants with a positive QFT-IT
test (suspected LTBI) compared to participants with a negative test
(suspected non-LTBI). The regression model was adjusted for sex,
age, CD4 and HIV status. The result of the regression model is
presented in an online data supplement (Data S1).
Discussion
These data affirms the fact that LTBI is highly prevalent among
urban Tanzanians, also among people with no known exposure or
history of TB. Furthermore, our data indicate that LTBI may be
associated with subclinical inflammation. In Tanzania, the
national HIV prevalence (in 2007) was estimated to be 5.7%
[11] while little is known about the present prevalence of LTBI in
Tanzania. Corbett E et al estimated in 2000 that 33% of the adult
population in Tanzania is infected with M. tuberculosis [12]. Based
on the results of the QFT-IT, we found that almost half of the
neighborhood controls to TB patients were LTBI, despite no
known source of TB exposure within the household. A study from
the northern part of Tanzania investigated the prevalence of LTBI
among pregnant women using the TST and reported a prevalence
between 26.2–37.4% [13]. The median age of those screened was
25 years ranging from 16–40 years. In line with this study we
found 35. 9% to be QFT-IT positive among women younger than
40 years. Our results are in line with data from a study conducted
in Ethiopia, also one of the world’s 22 TB high burden countries,
where an LTBI prevalence of 51% was found among healthy
blood donors using the QFT-IT [14]. Whether the neighborhood
controls are representative of the general population in Mwanza
City and Tanzania as a whole can be discussed. Our study design
where the neighborhood controls was recruited through a verified
TB patient introduce a possibility of bias toward a higher
prevalence of LTBI since we do not have any estimates regarding
the zone of influence a TB case may exercise on the community. A
previous study has pointed out that a TB case might influence the
incidence of TB up to 10th household in either direction [15]. In
our study the neighborhood controls were living within a distance
of 10–20 houses of a known TB patient. Although we used
confirmed TB patients to localize household contacts and
neighborhood controls we did not perform QFT-IT on the exact
TB patient giving rise to the following household contact and
neighborhood controls. However a previous study [16] likewise
nested within the framework of the two nutrition studies among
TB patients [9,10] found 74% to be QFT-IT positive. The positive
proportion of 41% LTBI in an urban setting of Mwanza, the 2nd
largest city in Tanzania, implies that TB transmission is certainly
taking place in this region. The fact that the four different TB
clinics which participated in the study ensured that most of the city
area was covered and we believe that our findings are valid as a
crude estimate of the prevalence of LTBI in Mwanza city.
Preventive treatment of LTBI with isoniazid has been shown to
reduce the risk of future disease by 75%–90% [17] and a positive
TST has proven useful to identify individuals who benefits from
isoniazid treatment [2]. Although this finding is not yet proven for
QFT-IT it is likely that the same applies for QFT-IT positive
individuals [2]. Among household contacts we found nearly 60%
to be QFT-IT positive and 13% to be HIV positive. It is not
surprising to find a higher prevalence of QFT-IT positives in this
population and cost effectiveness studies of systematic testing and
treatment of household contacts are clearly warranted.
Whether the IGRAs should replace the TST in low- and
middle-income countries for the diagnostic of LTBI has not been
within the study objectives to determine. WHO strongly discour-
ages the use of IGRAs for the diagnostics of LTBI in low- and
middle-income countries [18] partly due to insufficient data on the
performance of IGRAs and partly due to increased cost of IGRAs
compared to TST. We do not find that our study has the strength
to challenge this policy statement. However, our study confirms
previous findings that prior BCG vaccination do not affect the
QFT-IT result [19] and we also did not find any association
between age and LTBI. However we found an association
between LTBI and elevated levels of the acute phase protein
AGP among otherwise healthy neighborhood controls, which to
our knowledge has not been reported previously. AGP is
synthesized in the liver [7] and involved in the induction of non-
specific resistance to infection [20,21]. AGP levels are elevated in
patients with active TB [7] and it may be a possible marker of slow
response to anti-TB treatment [8]. The elevated AGP levels found
among neighborhood controls with LTBI warrant further studies.
We need to assess whether people with LTBI and elevated AGP
are in fact active TB in an early phase, or whether LTBI may
cause chronic low grade inflammation. Likewise further studies are
needed in order to determine whether living with elevated markers
of inflammation has any implications on the general health status.
Low-grade inflammation plays a role in the pathogenesis of
diabetes mellitus type II [22], and since diabetes is known to be
associated with TB [23,24], this may be one of several links
between the two diseases.
Conclusion
LTBI is highly prevalent among apparently healthy urban
Tanzanians even without known exposure to TB in the household.
LTBI was found to be associated with elevated serum levels of
AGP. This may reflect a state of low-grade inflammation and
could represent a possible link between diabetes mellitus type II
and TB.
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